Replies to post #14544 on GTC Biotherapeutics (fka GTCB)

[gym gravity]

From RMF:

"4. An ATryn partnership in Japan. Japan has substantial sales of plasma-derived antithrombin, including an approved indication for DIC/sepsis. These plasma-derived sales represent low-hanging fruit for eventual conversion to ATryn. At least one Japanese clinical study will be needed to obtain marketing approval. Dr. Cox has said that a deal is more likely in 2009 than in 2008."


those are off-label plasma derived antithrombin $s in japan?